Agenda

Return

C. 29

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	May 2, 2017

Contra

Costa

County

Subject:

Purchase Order with Roche Diagnostics Corp.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 05/02/2017

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 925-370-5101
cc:	Tasha Scott Marcy Wilhelm Margaret Harris

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: May 2, 2017
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and Authorize the Purchasing Agent, on behalf of the Health Services Department, to execute a Purchase Order with Roche Diagnostics Corp., in an amount not to exceed $790,148 for purchase of reagents and supplies for the Contra Costa Regional Medical Center (CCRMC) for the period of May 1, 2017 through April 30, 2022.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprises Fund I budget.

BACKGROUND:

CCRMC uses the Surepath Pap Smear for its patients. Roche Diagnostics Corp. has the only Food and Drug Administration approved Human papillomavirus (HPV) test on Surepath medium. One single specimen vial can perform both HPV and pap-test. The HPV test is able to detect a total of 14 HPV high risk types.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the Pathology department will not be able to efficiently and effectively detect cervical cancer in women since the HPV test with the pap together is the only screening test for this cancer.